Department of Veterinary Disease Biology, Faculty of Life Sciences, University of Copenhagen is offering a PhD project commencing 1/1 2011 or soon thereafter. The application deadline is December 1st 2010.
The Faculty of Life Science and Novo Nordisk A/S have recently established a research centre - The Novo Nordisk-LIFE In Vivo Pharmacology Centre (NNLIVPC) - with a total budget of DKK 68 mill covering activities until end 2018. The present positions are part of the new Centre´s activities. The purpose of the research centre is to strengthen the research in experimental pharmacology and toxicology and to increase the output of candidates and PhDs with a strong in vivo pharmacological profile. It is expected that the future PhD fellows will be enrolled in the In Vivo Pharmacology PhD program at LIFE and participate actively in this network. The In Vivo Pharmacology PhD program was established in 2006 as a collaboration between the Faculties of Life Sciences, Pharmaceutical Sciences and Health Sciences at the University of Copenhagen, University of Aarhus, and industrial partners; Novo Nordisk A/S, LEO Pharma and H. Lundbeck A/S.
Obesity, increased visceral fat mass, and liver steatosis (fat in liver) are factors associated with increased risk of developing cardiovascular disease. A common side effect following insulin therapy is weight gain - an issue for patients with type 2 diabetes as they often are obese when starting on insulin therapy. At present, the association between insulin-induced weight gain in type 2 diabetic individuals and the risk of developing cardiovascular disease is unclear.
With this project we wish to i) establish how insulin-induced obesity is associated with visceral fat mass and liver steatosis in an animal model of type 2 diabetes, ii) investigate how such changes are associated with relevant blood and tissue markers of inflammation and cardiovascular disease, and iii) investigate how insulin-induced weight gain in patients with type 2 diabetes is associated with changes in markers of cardiovascular disease.Contact:
Professor Jens Lykkesfeldt
Direct Phone: (+45) 35333163
Cardiovascular Toxicology Ph D Studentship (Fixed Term), University of Cambridge, United Kingdom, 29 days ago
Developing a human model of drug-induced vascular injury to determine the mechanisms of cardiovascular toxicity An exciting opportunity has arisen for a PhD student to work on a project funded by ...
Ph D Studentship: Spectroscopic Detection Of Biomarkers For Monitoring Health And Disease, The University of Southampton, United Kingdom, 9 days ago
Clinical and Experimental Sciences Location: Southampton General Hospital Closing Date: Monday 14 September 2015 Interview Date: Reference: 610115FC Lead Institute / Faculty: CES, Medicine Main S...
Ph D Scholarship In Loading Of Microcontainers For Oral Drug Delivery, Technical University of Denmark, Denmark, 8 days ago
Apply no later than 24 September 2015 Apply for the job at DTU Nanotech by completing the following form. Apply online DTU Nanotech conducts cross-disciplinary research where micro- and nanotechno...
Ph D Student Matrix Metalloproteinases As New Target To Prevent Epilepsy, AMC Medical Research, Netherlands, 23 days ago
Job posted by AcademicTransfer (05/08/2015 03.30) Marie Curie Actions. More 'HR Excellence in Research' logo awarded to institutions actively implementing the European Charter and Code for Researc...
Ph D Studentship: Complexity Of Flow Motion, The University of Southampton, United Kingdom, 29 days ago
Bioengineering Research Group Location: Highfield Campus Closing Date: Friday 30 October 2015 Interview Date: Reference: 601515BX A major challenge facing public health is the increased incidence ...
Three Ph D Scholarships At The Interface Of Synthetic Biology, Metagenomics And Bacterial Evolution, Technical University of Denmark, Denmark, 9 days ago
Apply no later than 30 September 2015 Apply for the job at Center for Biosustainability by completing the following form. Apply online We are seeking 3 PhD students to become part of the Phenotyp...